• Find us on Facebook
  • Follow BMJ OnExamination on Twitter

Latest News

Like this article?

Click vote now

0

Takotsubo cardiomyopathy.

from Heart - 20 May 14

Takotsubo cardiomyopathy. Heart. 2014 May 16; Authors: Pant S, Patel NJ, Deshmukh A PMID: 24837986 [PubMed - as supplied by publisher]



0

Association between blood pressure and risk of cardiovascular hospital admissions among people with type 2 diabetes.

from Heart - 20 May 14

Association between blood pressure and risk of cardiovascular hospital admissions among people with type 2 diabetes. Heart. 2014 May 16; Authors: Yu D, Simmons D Abstract OBJECTIVE: To investigate the association between systolic and diastolic blood pressure (BP) and risk of hospitalisation among patients with type 2 diabetes. METHODS: 4704 patients with type 2 diabetes from 18 general practices in Cambridgeshire were included. BP was a



0

The ECG as a tool to determine atrial fibrillation complexity.

from Heart - 20 May 14

The ECG as a tool to determine atrial fibrillation complexity. Heart. 2014 May 16; Authors: Lankveld TA, Zeemering S, Crijns HJ, Schotten U Abstract The use of the ECG for atrial fibrillation (AF) in clinical daily practice is still limited to its diagnosis. Recent research shows however that ECG-derived parameters can also be used to assess the spatiotemporal properties of AF. Specifically, the complexity of the f-waves in the ECG reflects the



0

Persistent neo-aortic growth during adulthood in patients after an arterial switch operation.

from Heart - 20 May 14

Persistent neo-aortic growth during adulthood in patients after an arterial switch operation. Heart. 2014 May 16; Authors: van der Bom T, van der Palen RL, Bouma BJ, van Veldhuisen SL, Vliegen HW, Konings TC, Zwinderman AH, Blom NA, Koolbergen DR, Hazekamp MG, Mulder BJ Abstract OBJECTIVE: After the arterial switch operation (ASO), disproportional neo-aortic growth during childhood has been reported. Even though it has been suggested neo-aortic



0

PETER RUSSELL KOWEY, MD: a conversation with the editor.

from Am J Cardiol - 20 May 14

PETER RUSSELL KOWEY, MD: a conversation with the editor. Am J Cardiol. 2014 Jun 1;113(11):1917-32 Authors: Kowey PR, Roberts WC PMID: 24837274 [PubMed - in process]



0

Relation between echocardiographically estimated and invasively measured filling pressures in constrictive pericarditis.

from Am J Cardiol - 20 May 14

Relation between echocardiographically estimated and invasively measured filling pressures in constrictive pericarditis. Am J Cardiol. 2014 Jun 1;113(11):1911-6 Authors: Alraies MC, Kusunose K, Negishi K, Yarmohammadi H, Motoki H, AlJaroudi W, Popovic ZB, Klein AL Abstract The ratio of early transmitral flow velocity (E) to mitral annular velocity (E') is considered a predictor of pulmonary capillary wedge pressure (PCWP). In a previous small s



0

Impact of Acute Kidney Injury on In-Hospital Outcomes in Patients With DeBakey Type III Acute Aortic Dissection.

from Am J Cardiol - 20 May 14

Impact of Acute Kidney Injury on In-Hospital Outcomes in Patients With DeBakey Type III Acute Aortic Dissection. Am J Cardiol. 2014 Jun 1;113(11):1904-10 Authors: Takahashi T, Hasegawa T, Hirata N, Endo A, Yamasaki Y, Ashida K, Kabeya Y, Nakagawa S Abstract The relation between the incidence and severity of acute kidney injury (AKI) and clinical outcomes remains unclear in patients with DeBakey type III acute aortic dissection (AAD). We retrosp



0

Assessment of cardiovascular and noncardiovascular medical device recalls.

from Am J Cardiol - 20 May 14

Assessment of cardiovascular and noncardiovascular medical device recalls. Am J Cardiol. 2014 Jun 1;113(11):1899-903 Authors: Somberg JC, McEwen P, Molnar J Abstract Medical device recalls have called attention to the device approval process in the United States. The premarket approval (PMA) process requires clinical trials to evaluate safety and effectiveness, whereas the expedited 510(k) process does not. The 510(k) process has been considere



0

Incidence, predictors, and impact on survival of left ventricular systolic dysfunction and recovery in advanced cancer patients.

from Am J Cardiol - 20 May 14

Incidence, predictors, and impact on survival of left ventricular systolic dysfunction and recovery in advanced cancer patients. Am J Cardiol. 2014 Jun 1;113(11):1893-8 Authors: Oliveira GH, Mukerji S, Hernandez AV, Qattan MY, Banchs J, Durand JB, Iliescu C, Plana JC, Tang WH Abstract Although left ventricular (LV) dysfunction occurs not uncommonly in the course of cancer therapy, little is known about its natural history and prognostic impact



0

Three-dimensional echocardiography and cardiac magnetic resonance imaging in the screening of long-term survivors of childhood cancer after cardiotoxic therapy.

from Am J Cardiol - 20 May 14

Three-dimensional echocardiography and cardiac magnetic resonance imaging in the screening of long-term survivors of childhood cancer after cardiotoxic therapy. Am J Cardiol. 2014 Jun 1;113(11):1886-92 Authors: Ylänen K, Eerola A, Vettenranta K, Poutanen T Abstract The left ventricular (LV) volumes, ejection fraction (EF), and dyssynchrony indexes for the 16 and 12 cardiac segments (Tmsv16-SD and Tmsv12-SD, respectively) were analyzed among non



0

Differences in global and regional left ventricular myocardial mechanics in various morphologic subtypes of patients with obstructive hypertrophic cardiomyopathy referred for ventricular septal myotom

from Am J Cardiol - 20 May 14

Differences in global and regional left ventricular myocardial mechanics in various morphologic subtypes of patients with obstructive hypertrophic cardiomyopathy referred for ventricular septal myotomy/myectomy. Am J Cardiol. 2014 Jun 1;113(11):1879-85 Authors: Kobayashi T, Dhillon A, Popovic Z, Bhonsale A, Smedira NG, Thamilarasan M, Lytle BW, Lever HM, Desai MY Abstract Patients with obstructive hypertrophic cardiomyopathy (HC) have various l



0

Analysis of geographic variations in the diagnosis and treatment of patients with aortic stenosis in north Carolina.

from Am J Cardiol - 20 May 14

Analysis of geographic variations in the diagnosis and treatment of patients with aortic stenosis in north Carolina. Am J Cardiol. 2014 Jun 1;113(11):1874-8 Authors: Vavalle JP, Phillips HR, Holleran SA, Wang A, O'Connor CM, Smith PK, Hughes GC, Harrison JK, Patel MR Abstract Despite advances in the treatment of aortic stenosis (AS), many patients with AS remain untreated. Barriers to accessing cardiovascular surgical care may play a role in th



0

Prevalence of calcification of the mitral valve annulus in patients undergoing surgical repair of mitral valve prolapse.

from Am J Cardiol - 20 May 14

Prevalence of calcification of the mitral valve annulus in patients undergoing surgical repair of mitral valve prolapse. Am J Cardiol. 2014 Jun 1;113(11):1867-73 Authors: Fusini L, Ghulam Ali S, Tamborini G, Muratori M, Gripari P, Maffessanti F, Celeste F, Guglielmo M, Cefalù C, Alamanni F, Zanobini M, Pepi M Abstract Factors correlating to mitral annulus calcification (MAC) include risk factors predisposing to atherosclerosis. In patients with



0

Comparison of two- and three-dimensional transthoracic echocardiography to cardiac magnetic resonance imaging for assessment of paravalvular regurgitation after transcatheter aortic valve implantation

from Am J Cardiol - 20 May 14

Comparison of two- and three-dimensional transthoracic echocardiography to cardiac magnetic resonance imaging for assessment of paravalvular regurgitation after transcatheter aortic valve implantation. Am J Cardiol. 2014 Jun 1;113(11):1859-66 Authors: Altiok E, Frick M, Meyer CG, Al Ateah G, Napp A, Kirschfink A, Almalla M, Lotfi S, Becker M, Herich L, Lehmacher W, Hoffmann R Abstract This study evaluated 2-dimensional (2D) transthoracic echoca



0

A Simple Risk Tool (the OBSERVANT Score) for Prediction of 30-Day Mortality After Transcatheter Aortic Valve Replacement.

from Am J Cardiol - 20 May 14

A Simple Risk Tool (the OBSERVANT Score) for Prediction of 30-Day Mortality After Transcatheter Aortic Valve Replacement. Am J Cardiol. 2014 Jun 1;113(11):1851-8 Authors: Capodanno D, Barbanti M, Tamburino C, D'Errigo P, Ranucci M, Santoro G, Santini F, Onorati F, Grossi C, Covello RD, Capranzano P, Rosato S, Seccareccia F, OBSERVANT Research Group Abstract Risk stratification tools used in patients with severe aortic stenosis have been mostly



0

Afterload Mismatch After MitraClip Insertion for Functional Mitral Regurgitation.

from Am J Cardiol - 20 May 14

Afterload Mismatch After MitraClip Insertion for Functional Mitral Regurgitation. Am J Cardiol. 2014 Jun 1;113(11):1844-50 Authors: Melisurgo G, Ajello S, Pappalardo F, Guidotti A, Agricola E, Kawaguchi M, Latib A, Covello RD, Denti P, Zangrillo A, Alfieri O, Maisano F Abstract Afterload mismatch, defined as acute impairment of left ventricular function after mitral surgery, is a major issue in patients with low ejection fraction and functional



0

Usefulness of elevated urine neopterin levels in assessing cardiac dysfunction and exercise ventilation inefficiency in patients with chronic systolic heart failure.

from Am J Cardiol - 20 May 14

Usefulness of elevated urine neopterin levels in assessing cardiac dysfunction and exercise ventilation inefficiency in patients with chronic systolic heart failure. Am J Cardiol. 2014 Jun 1;113(11):1839-43 Authors: Shao Z, Zhang R, Shrestha K, Borowski AG, Schuster A, Thakur A, Hazen SL, Tang WH Abstract Neopterin is synthesized by macrophages upon stimulation with gamma-interferon, and high neopterin production is associated with cellular imm



0

Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.

from Am J Cardiol - 20 May 14

Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions. Am J Cardiol. 2014 Jun 1;113(11):1834-8 Authors: Bavishi C, Ather S, Bambhroliya A, Jneid H, Virani SS, Bozkurt B, Deswal A Abstract Hyponatremia in heart failure (HF) is an established predictor of adverse outcomes in hospitalized patients with reduced ejection fraction (EF). However, there is a paucity of data in



0

Effects of individualized exercise training in patients with catecholaminergic polymorphic ventricular tachycardia type 1.

from Am J Cardiol - 20 May 14

Effects of individualized exercise training in patients with catecholaminergic polymorphic ventricular tachycardia type 1. Am J Cardiol. 2014 Jun 1;113(11):1829-33 Authors: Manotheepan R, Saberniak J, Danielsen TK, Edvardsen T, Sjaastad I, Haugaa KH, Stokke MK Abstract Ventricular arrhythmias (VAs) in patients with catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) are triggered at an individual and reproducible heart rate (HR



0

Demonstration of anatomic reentrant circuit in verapamil-sensitive atrial tachycardia originating from the atrioventricular annulus other than the vicinity of the atrioventricular node.

from Am J Cardiol - 20 May 14

Demonstration of anatomic reentrant circuit in verapamil-sensitive atrial tachycardia originating from the atrioventricular annulus other than the vicinity of the atrioventricular node. Am J Cardiol. 2014 Jun 1;113(11):1822-8 Authors: Yamabe H, Okumura K, Koyama J, Kanazawa H, Hoshiyama T, Ogawa H Abstract The mechanism and tachycardia circuit of verapamil-sensitive atrial tachycardia originating from the atrioventricular annulus (AVA-AT) other



0

Risk of atrial fibrillation with use of oral and intravenous bisphosphonates.

from Am J Cardiol - 20 May 14

Risk of atrial fibrillation with use of oral and intravenous bisphosphonates. Am J Cardiol. 2014 Jun 1;113(11):1815-21 Authors: Sharma A, Einstein AJ, Vallakati A, Arbab-Zadeh A, Walker MD, Mukherjee D, Homel P, Borer JS, Lichstein E Abstract Clinical studies suggest an association between bisphosphonate use and new-onset atrial fibrillation (AF). Intravenous bisphosphonates more potently increase the release of inflammatory cytokines than do o



0

Risk of stroke in patients with high on-clopidogrel platelet reactivity to adenosine diphosphate after percutaneous coronary intervention.

from Am J Cardiol - 20 May 14

Risk of stroke in patients with high on-clopidogrel platelet reactivity to adenosine diphosphate after percutaneous coronary intervention. Am J Cardiol. 2014 Jun 1;113(11):1807-14 Authors: Taglieri N, Bacchi Reggiani ML, Palmerini T, Ghetti G, Saia F, Gallo P, Moretti C, Dall'Ara G, Marrozzini C, Marzocchi A, Rapezzi C Abstract Several prospective studies have shown that high on-clopidogrel platelet reactivity (HPR) in patients undergoing percu



0

Comparison of Outcomes After Percutaneous Coronary Intervention Among Different Coronary Subsets (Stable and Unstable Angina Pectoris and ST-Segment and Non-ST-Segment Myocardial Infarction).

from Am J Cardiol - 20 May 14

Comparison of Outcomes After Percutaneous Coronary Intervention Among Different Coronary Subsets (Stable and Unstable Angina Pectoris and ST-Segment and Non-ST-Segment Myocardial Infarction). Am J Cardiol. 2014 Jun 1;113(11):1794-801 Authors: Loh JP, Pendyala LK, Kitabata H, Torguson R, Omar A, Minha S, Chen F, Satler LF, Pichard AD, Waksman R Abstract Percutaneous coronary intervention in the setting of acute myocardial infarction is known to



0

Outcomes of coronary stenoses deferred revascularization for borderline versus nonborderline fractional flow reserve values.

from Am J Cardiol - 20 May 14

Outcomes of coronary stenoses deferred revascularization for borderline versus nonborderline fractional flow reserve values. Am J Cardiol. 2014 Jun 1;113(11):1788-93 Authors: Depta JP, Patel JS, Novak E, Masrani SK, Raymer D, Facey G, Patel Y, Zajarias A, Lasala JM, Singh J, Bach RG, Kurz HI Abstract Current evidence supports deferral of revascularization for lesions with fractional flow reserve (FFR) values >0.80. The natural history after



0

Perceived Lifetime Risk for Cardiovascular Disease (from the Dallas Heart Study).

from Am J Cardiol - 20 May 14

Perceived Lifetime Risk for Cardiovascular Disease (from the Dallas Heart Study). Am J Cardiol. 2014 Apr 18; Authors: Petr EJ, Ayers CR, Pandey A, de Lemos JA, Powell-Wiley TM, Khera A, Lloyd-Jones DM, Berry JD Abstract Lifetime risk estimation for cardiovascular disease (CVD) has been proposed as a useful strategy to improve risk communication in the primary prevention setting. However, the perception of lifetime risk for CVD is unknown. We in


 

9017 items Page 135 of 361 << 130 131 132 133 134 135 136 137 138 139 140 >>

    Search

    Categories

    Keyword cloud

    Abstract blood brain Breast cardiac cardiovascular chronic CI cohort Diabetes dog England genetic healthy HIV included injury pain participants performed protein Randomized screening supplied volume

    Top news voters

    ajaykuks1 vote

    © 2014 BMJ Publishing Group Ltd . All rights reserved.